Cabometyx, inncabozantinib european medicines agency. Eocco010 description cabozantinib cabometyx, cometriq is an orally administered tyrosine kinase inhibitor of ret, met, vegfr123, kit, trkb, flt3, and tie2. Highlights of prescribing information tafinlar with. If you have difficulty viewing the document below, please click here to view the full prescribing information, including the boxed warning. The incidence of grade 3 to 5 hemorrhagic events was 5% in cabometyx. Talk to your healthcare provider about the risks and benefits of using this medication when pregnant see. History of serious hypersensitivity reactions, including anaphylaxis, to oncaspar or to any of the excipients. See full prescribing information for complete boxed. Cabometyx cabozantinib tablets and cometriq cabozantinib capsules are not bioequivalent and should not be used interchangeably see section 5. Cometriq 80mg gelatin capsules are swedish orange with xl184 80mg printed in black on the body of the capsule.
Cometriq, cabometyx cabozantinib dosing, indications. Cabozantinib, sold under the brandname cabometyx and cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. Cometriq is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer mtc. Highlights of prescribing information cardiac dysfunction. Tell your healthcare provider if you plan to have any surgery before or during treatment with cabometyx.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. Cometriq 20mg gelatin capsules are grey with xl184 20mg printed in black on the body of the capsule. Although patients with thyroid cancer generally fare well, there is a subset for which this is not necessarily true. Monitor hepatic function prior to and during treatment see warnings and precautions 5. Unresectable locoregional disease that is symptomatic or structurally progressive. It is a small molecule inhibitor of the tyrosine kinases cmet and vegfr2, and also inhibits axl and ret. Highlights of prescribing information antiplatelet. If patients must be coadministered a strong cyp3a4 inducer, based on pharmacokinetic studies, a torisel dose increase from 25 mgweek up to 50 mgweek should be considered. Please see the accompanying full prescribing information for cometriq. Zivaflibercept acts as a soluble receptor that binds to human vegfa equilibrium dissociation constant kd of 0.
Refer to the dabrafenib prescribing information for recommended dabrafenib dosing information. Authorization of 24 months may be granted to members prescribed cometriq for medullary thyroid cancer whose disease meets one of the following. Cometriq cabozantinib 100mg dailydose pack 1 dose pack 56 capsules per 28 days cometriq cabozantinib 140mg dailydose pack 1 dose pack 112 capsules per 28 days approval criteria requests for cometriq cabozantinib capsules may be approved if the following criteria are met. Cabometyx cabozantinib tablets and cometriq cabozantinib capsules are not. On december 19, 2017, the food and drug administration granted regular approval to cabozantinib cabometyx, exelixis, inc.
Coronavirus covid19 update at exelixis, we remain committed to serving the needs of people who take cabometyx. It is an oral receptor tyrosine kinase inhibitor for more detail. In 2012 cabozantinib in its capsule formulation was. Accelerated approval was granted for fl and sll based on. Eocco010 description cabozantinib cabometyx, cometriq is an orally administered tyrosine kinase inhibitor of ret, met. Cabometyx cabozantinib is contraindicated in patients who are. The clinically important adverse reactions observed in trials comparing plavix plus aspirin to placebo plus aspirin and trials comparing plavix alone to aspirin alone are discussed below. Feb 14, 2020 cabozantinib smalate salt is a white to offwhite solid that is practically insoluble in aqueous media. Stivarga regorafenib is a prescription medicine used to treat people with. Instruct patients not to eat for at least 2 hours before and at least 1 hour after taking cabometyx. The most common laboratory abnormalities incidence. This medicinal product is subject to additional monitoring.
Oncology related including new drugs, antagonists, etc. Cometriq may react with a number of other medications see cometriq drug interactions. Highlights of prescribing information palmarplantar. Cabometyx cabozantinib is indicated for the treatment of patients with hepatocellular carcinoma hcc who have been previously treated with sorafenib. Cometriq is a prescription medicine used to treat people with medullary thyroid cancer mtc that has spread to other parts of the body called metastatic mtc it is not known if cometriq is safe and effective in children. In some cases, health care professionals may use the generic name cabozantinib when referring to the trade name cometriq.
Official site for healthcare professionals nexavar. Please scroll down to see important safety information for cometriq and click here to see the full prescribing information. You should stop taking cabometyx at least 3 weeks before planned surgery. Highlights of prescribing information perforation can.
If a patient must switch from cabozantinib capsules to cabozantinib tablets, the patient should continue at a cabometyx dose not to exceed 60 mg or the current cometriq dose whichever is lower. Cabozantinib smalate salt is a white to offwhite solid that is practically insoluble in aqueous media. Talk to your healthcare provider about the risks and benefits of using this medication when pregnant see cometriq and pregnancy. Coadministration with a strong cyp3a4 inhibitor increased the exposure of cabozantinib, which may increase the risk of exposurerelated adverse reactions. Do not administer cometriq to patients with a recent history of hemorrhage, including hemoptysis, hematemesis, or melena. Start with nexavar sorafenib as a foundation for a systemic treatment plan 15. It is not known if cometriq is safe and effective in children.
This emedtv web page discusses why cometriq is only used when the cancer has progressed to other areas of the body. Dec 23, 2019 cometriq 20mg gelatin capsules are grey with xl184 20mg printed in black on the body of the capsule. Cometriq is prescribed to treat medullary thyroid cancer in adults. History of serious thrombosis with prior lasparaginase therapy. Cabometyx cabozantinib is indicated for the treatment of patients with. Cometriq has been shown to inhibit the activity of met. The clinically important adverse reactions observed in trials comparing plavix plus aspirin to placebo plus aspirin and trials comparing plavix alone to. Full text the treatment landscape in thyroid cancer. Cabozantinib in patients with advanced and progressing. Side effects of cometriq cabozantinib capsules, warnings, uses. Carefirst bluecross blueshield is the shared business name of carefirst of maryland, inc. Cometriq treatment results in an increased incidence of treatmentemergent hypertension with joint national committee on prevention, detection, evaluation, and treatment of high blood pressure modified jnc criteria stage 1 or 2 hypertension identified in 61% in cometriqtreated patients compared with 30% of placebotreated patients in the randomized trial. If previously receiving 60 mg daily dose, resume treatment at 40 mg daily.
Erivedge vismodegib capsules, for oral use initial u. Blinatumomab is a bispecific cd19directed cd3 tcell engager that binds to cd19 expressed on the surface of cells of blineage origin and. Plavix has been evaluated for safety in more than 54,000 patients, including over 21,000 patients treated for one year or more. For disease that is of predominantly clear cell histology, cometriq will be used for disease that has progressed on prior antiangiogenic therapy e. Highlights of prescribing information these highlights do not. The antiangiogenic ceiling in hepatocellular carcinoma. Do not substitute cabometyx tablets with cabozantinib capsules. Hepatotoxicity severe and sometimes fatal hepatotoxicity has occurred in clinical trials see warnings and precautions 5. Severe and sometimes fatal hepatotoxicity has occurred in clinical trials. Interrupt and then reduce or discontinue stivarga for hepatotoxicity as manifested by elevated liver. Asymptomatic distant metastases if structurally progressive and unresectable iii. Gastrointestinal perforations occurred in 3% and fistula formation in 1% of.
Oncaspar pegaspargase is indicated as a component of a multiagent chemotherapeutic regimen for the treatment of pediatric and adult patients with. These tyrosine kinases are involved in both normal cellular function and pathologic processes, such as. Cometriq is a cancer medicine that contains the active substance cabozantinib smalate. Protein in your urine and possible kidney problems.
Cometriq while maintaining optimal therapeutic outcomes. Cometriq is the trade name for the generic chemotherapy drug cabozantinib. Severe and fatal hemorrhages occurred with cabometyx. Highlights of prescribing information when administering. Coadministration with a strong cyp3a4 inhibitor increased the exposure of cabozantinib, which may increase the. Cometriq fda prescribing information, side effects and uses.
Feb 14, 2020 nearly all cometriq treated patients 96% vs. Side effects of cometriq cabozantinib capsules, warnings. Fatal andor serious and severe diarrhea or colitis occurred in 14% to 19% of zydeligtreated patients. Cometriq increased the incidence of thrombotic events venous thromboembolism. Nccn clinical practice guidelines in oncology nonsmall cell lung cancer version 3. It is a medicine used to treat medullary thyroid cancer, a rare type of. Is caused by a defect in a gene called anaplastic lymphoma kinase alk and has spread to other parts of the body.
Cometriq cabozantinib capsules are supplied as printed hard gelatin capsules containing cabozantinib smalate equivalent to 20 mg or 80 mg cabozantinib and the following inactive ingredients. Unresectable locoregional disease that is symptomatic or structurally progressive ii. Administration of a strong cyp3a4 inhibitor, ketoconazole to healthy subjects increased singledose plasma cabozantinib exposure by 38% cabometyx. Your healthcare provider should tell you when you may start taking cabometyx again after surgery. Labeling package insert, labelingcontainercarton labels. The printed package leaflet of the medicinal product must state the name and address of the. It also offers an explanation of how this drug works. Cometriq cabozantinib is a cancer medicine indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer mtc 1,2. The use of concomitant strong cyp3a4 inducers should be avoided e. Cabozantin cabometyx, cometriq eocco policy policy type.
Monitor for the development of severe diarrhea or colitis. Highlights of prescribing information these highlights do. Tell your healthcare provider right away if you have rashes, redness, pain, swelling, or blisters on the palms of your hands or soles of your feet. Zykadia is a prescription medicine that is used to treat people with nonsmall cell lung cancer nsclc that. Cometriq cabozantinib capsules 100 mg daily dose blister cards each 100 mg daily dose contains a combination of one swedish orange 80 mg and one grey 20 mg capsule. Cometriq is a pregnancy category d medication, which means it may harm an unborn child. Cometriq cabozantinib is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer mtc. Package label carton 100 mg daily dose of cometriq. Handfoot skin reactions are common with cometriq and can be severe. Our cometriq cabozantinib side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this medication. Cometriq is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body.
122 38 144 1372 1421 95 1369 1441 901 50 1257 381 807 378 1002 221 582 1303 1253 500 590 636 436 444 767 1496 587 861 1197